Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Efficacy of LY2784544, a Small Molecule Inhibitor Selective for Mutant JAK2 Kinase, In JAK2 V617F -Induced Hematologic Malignancy Models

Liandong Ma, Ph., D, Baohui Zhao, Ms, Richard Walgren, MD, PhD, Joshua A Clayton, MS, Wayne D Blosser, Timothy P Burkholder, Ph.D, Michele C Smith, PhD

Blood (2010) 116 (21): 4087.

https://doi.org/10.1182/blood.V116.21.4087.4087

Published: 2010

Journal Articles

LY2784544, a Novel JAK2 Inhibitor, Decreases In Vitro Growth of Hematopoietic Human Progenitors From JAK2 V617F Positive Polycythemia Vera Patients

Lourdes Florensa, Beatriz Bellosillo, Leonor Arenillas, Liandong Ma, Ph., D, Richard Walgren, MD, PhD, Alberto Alvarez, Judit Gonzalez, Rosa M Vila, Raquel Longarón, Carles Besses

Blood (2010) 116 (21): 5054.

https://doi.org/10.1182/blood.V116.21.5054.5054

Published: 2010

Journal Articles

Azacitidine-Induced Changes in the MDS Methylome Are Associated with Clinical Responses

Michael G. Martin, MD, Richard Walgren, MD, PhD, Elizabeth Procknow, Peter Westervelt, MD, PhD, Camille N Abboud, MD, Amanda F Cashen, MD, Keith Stockerl-Goldstein, MD, Feng Gao, PhD, John F DiPersio, MD, PhD, Ravi Vij, MD

Blood (2008) 112 (11): 2691.

https://doi.org/10.1182/blood.V112.11.2691.2691

Published: 2008

Journal Articles

A Genome-Wide Analysis to Identify Novel Susceptibility Loci for Therapy-Related Acute Myeloid Leukemia

Kenan Onel, MD, PhD, Jeffrey A Knight, Andrew D Skol, PhD, Thelma R Tennant, Mekhala Banerjee, Richard Walgren, MD, PhD, Jin Shao, James M Allan, MD, Michelle M Le Beau, PhD, Richard A Larson, MD, Timothy Graubert, MD, Nancy J Cox, PhD

Blood (2008) 112 (11): 432.

https://doi.org/10.1182/blood.V112.11.432.432

Published: 2008

Journal Articles

Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia

Blood (2008) 111 (9): 4797–4808.

https://doi.org/10.1182/blood-2007-09-113027

Published: 2008

Includes: Supplemental data

Journal Articles

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Richard Walgren, MD, PhD, Crystal Dao, MA, Frederieke Kreisel, MD, Peter Westervelt, MD, PhD, Camille Abboud, MD, Timothy Graubert, MD, Amanda Cashen, MD, Geoffrey Uy, MD, Feng Gao, MD, John DiPersio, MD, PhD, Ravi Vij, MD

Blood (2007) 110 (11): 1451.

https://doi.org/10.1182/blood.V110.11.1451.1451

Published: 2007

Journal Articles

Identification of Polymorphisms Associated with Susceptibility to Therapy-Related MDS and AML.

Richard Walgren, MD, PhD, Edward McLaughlin, BSc, Elise Peterson, BS, Michael Crosswhite, MA, Michael Province, PhD, Howard McLeod, PharmD, Timothy Ley, MD, Timothy Graubert, MD, Gareth Morgan, MD, PhD

Blood (2007) 110 (11): 15.

https://doi.org/10.1182/blood.V110.11.15.15

Published: 2007

NARROW

Efficacy of LY2784544, a Small Molecule Inhibitor Selective for Mutant JAK2 Kinase, In JAK2 V617F -Induced Hematologic Malignancy Models

LY2784544, a Novel JAK2 Inhibitor, Decreases In Vitro Growth of Hematopoietic Human Progenitors From JAK2 V617F Positive Polycythemia Vera Patients

Azacitidine-Induced Changes in the MDS Methylome Are Associated with Clinical Responses

A Genome-Wide Analysis to Identify Novel Susceptibility Loci for Therapy-Related Acute Myeloid Leukemia

Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Identification of Polymorphisms Associated with Susceptibility to Therapy-Related MDS and AML.

Email alerts

ASH Publications

American Society of Hematology

Efficacy of LY2784544, a Small Molecule Inhibitor Selective for Mutant JAK2 Kinase, In JAK2 V617F -Induced Hematologic Malignancy Models

LY2784544, a Novel JAK2 Inhibitor, Decreases In Vitro Growth of Hematopoietic Human Progenitors From JAK2 V617F Positive Polycythemia Vera Patients

Azacitidine-Induced Changes in the MDS Methylome Are Associated with Clinical Responses

A Genome-Wide Analysis to Identify Novel Susceptibility Loci for Therapy-Related Acute Myeloid Leukemia

Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Identification of Polymorphisms Associated with Susceptibility to Therapy-Related MDS and AML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only